Projects funded by the NCN

The role of kynurenine pathway in neurophatic pain in view of innovative treatment approaches

Call: SONATA 9 , Panel: NZ4

Principal investigator: dr Ewelina Joanna Rojewska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Prolonged-release of selected antiangiogenic proteins from innovative nanocarrier for use in adjuvant/additive multiple ...

Call: OPUS 28 , Panel: NZ7

Principal investigator: prof. Bogusław Bronisław Machaliński

Pomorski Uniwersytet Medyczny w Szczecinie

Innovative Small Molecule Inhibitors Targeting LAG-3 and MHCII Complex for Tumour Immunotherapy

Call: OPUS 27 , Panel: NZ7

Principal investigator: dr Jacek Plewka

Uniwersytet Jagielloński

Using DNA methylation markers and epigenetic clocks as an innovative tool to assess health, risk indicators, and manage ...

Call: OPUS 27 , Panel: NZ7

Principal investigator: dr hab. Ewelina Maria Pośpiech

Pomorski Uniwersytet Medyczny w Szczecinie

Synthesis, characterization, and evaluation of the biological activity of innovative thermosensitive suppositories compr...

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr hab. Ewa Olędzka

Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

Call: OPUS 26 , Panel: NZ7

Principal investigator: prof. Jadwiga Handzlik

Uniwersytet Jagielloński, Collegium Medicum

Exploring kinase hyperactivation as an innovative approach for chemo-immunotherapy for B cell acute lymphoblastic leukem...

Call: PRELUDIUM BIS 5 , Panel: NZ7

Principal investigator: dr hab. Małgorzata Firczuk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

The EU system of regulatory exclusivities and rewards - towards a better-balanced legal framework of access to healthcar...

Call: OPUS 25 , Panel: HS5

Principal investigator: dr Żaneta Zemła-Pacud

Instytut Nauk Prawnych Polskiej Akademii Nauk

unESKAPEable. Innovative antibiotics leads based on bifunctionalsed metallacarboranes to combat ESKAPE pathogens.

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Jakub Cebula

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Normalization of energy metabolism as a way to develop innovative antithrombotic therapies

Call: OPUS 21 , Panel: NZ7

Principal investigator: dr Patrycja Kaczara

Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search...

Call: OPUS 21 , Panel: NZ7

Principal investigator: prof. Marcin Roman Kołaczkowski

Uniwersytet Jagielloński, Collegium Medicum

In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Anna Karolina Pogorzelska

Narodowy Instytut Leków

An innovative method of treating acute liver failure using amniotic stem cells isolated from the human placenta.

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: dr Patrycja Lukrecja Wieczorek

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

Pulse electroporation as an innovative method in the process of the so-called root milking", use in the adaptation of me...

Call: SONATA 16 , Panel: NZ9

Principal investigator: dr Sylwester Ślusarczyk

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

Towards innovative strategy for treatment of Alzheimer's Disease via dual inhibition of receptor 5-HT6 and kinase CDK5.

Call: PRELUDIUM 19 , Panel: NZ7

Principal investigator: Sylwia Sudoł-Tałaj

Uniwersytet Jagielloński, Collegium Medicum

Ethics of research with human subjects in precision medicine

Call: PRELUDIUM 18 , Panel: HS1

Principal investigator: dr Karolina Maria Strzebońska

Uniwersytet Jagielloński, Collegium Medicum

Thymol-derived 1,3,5-triazines, the non-indole and non-sulfone 5-HT6 receptor ligands, as a starter in search for an inn...

Call: OPUS 16 , Panel: NZ7

Principal investigator: prof. Jadwiga Handzlik

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

New Hexokinase II inhibitors, in search of innovative therapeutic approaches to cancer treatment

Call: PRELUDIUM 14 , Panel: NZ7

Principal investigator: Mateusz Dawid Tomczyk

Politechnika Śląska, Wydział Chemiczny

Mitochondria transfer as an innovative method of restoring stemness of adipose-derived stem cells isolated from horses s...

Call: PRELUDIUM 14 , Panel: NZ7

Principal investigator: dr Katarzyna Beata Kornicka-Garbowska

Uniwersytet Przyrodniczy we Wrocławiu, Wydział Biologii i Hodowli Zwierząt

New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Michał Karol Załuski

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Innovative delivery systems of active pharmaceutical ingredients whose effectiveness needs frequent dosage algorithms

Call: SONATA 12 , Panel: NZ7

Principal investigator: dr Joanna Gościańska

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

INNOvative antiSEPTic agents for a therapy with a broad spectrum of action

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr Sebastian Kraszewski

Politechnika Wrocławska

New, innovative hybrid materials useful in regenerative medicine based soley on natural components

Call: OPUS 10 , Panel: ST8

Principal investigator: dr hab. Beata Kolesińska

Politechnika Łódzka, Wydział Chemiczny